Filing Details
- Accession Number:
- 0001062993-15-002056
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-20 16:03:44
- Reporting Period:
- 2015-04-16
- Filing Date:
- 2015-04-20
- Accepted Time:
- 2015-04-20 16:03:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1098880 | Intelgenx Technologies Corp. | IGXT | Pharmaceutical Preparations (2834) | 870638336 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1381868 | Ingrid Zerbe | 714 Main Road Hudson A8 J0P 1H0 | Corporate Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-16 | 14,950 | $0.68 | 513,185 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-16 | 2,550 | $0.69 | 510,635 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-16 | 2,500 | $0.69 | 508,135 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-17 | 5,175 | $0.66 | 502,960 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-17 | 14,825 | $0.65 | 488,135 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-17 | 10,000 | $0.65 | 478,135 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-17 | 10,000 | $0.66 | 468,135 | No | 4 | S | Direct | |
| Common Shares ($0.0001 Par Value) | Disposition | 2015-04-20 | 6,900 | $0.65 | 461,235 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares ($0.0001 Par Value) | 5,158,221 | Indirect | See footnote |
Footnotes
- In connection with the acquisition of IntelGenx in 2006, Ingrid Zerbe became our Corporate Secretary and Director of Finance and Administration and acquired 4,709,643.5 exchangeable Shares of our Canadian holding corporation 6544631Canada Inc., a Canadian special purpose corporation which wholly owns IntelGenx Corp. (the "Exchangeable Shares"). In June of 2009 Ms. Zerbe acquired 1,021,713 Exchangeable Shares from Joel Cohen in a private transaction. The 5,731,356.5 Exchangeable Shares are exchangeable, on a one for one basis, into shares of common stock of IntelGenx Technologies Corp. at Ms. Zerbe's discretion. As of today 573,135 exchangeable shares have been exchanged into common stock of IntelGenx Technologies Corp. Prior to exchanging the remaining Exchangeable Shares, Ms. Zerbe has the right to vote 5,158,221.5 shares of common stock which are currently held in trust on behalf of Ms. Zerbe. The common shares have not been registered for resale at this time.
Billionaire Hedge Funds
